Stay updated on Upadacitinib in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib in Atopic Dermatitis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Mostly a metadata update: the citation’s publication timing shifts from an early online ahead of print notice to a later October issue citation. Core meaning remains the same; treat as a minor timing update.
    Difference
    0.1%
    Check dated 2025-10-12T14:19:26.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    0.7%
    Check dated 2025-10-05T09:26:14.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Core page content is largely unchanged; however, several MedlinePlus topics were removed and the page version updated to v3.1.0, indicating a cleanup of topics rather than addition of new content.
    Difference
    0.1%
    Check dated 2025-09-28T03:09:09.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the old revision label was removed. The 'Back to Top' element was also removed, which is a minor UI change.
    Difference
    0.0%
    Check dated 2025-09-13T16:42:24.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page has been updated to include new research articles related to Upadacitinib, highlighting its safety and efficacy in various conditions, while the previous version has been removed.
    Difference
    1%
    Check dated 2025-09-06T14:08:02.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous facility locations across various countries and the inclusion of new research references related to upadacitinib. However, many previously listed locations and terms have been removed.
    Difference
    9%
    Check dated 2025-08-30T11:04:35.000Z thumbnail image

Stay in the know with updates to Upadacitinib in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.